Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 9 of 9 publications.

Spinner DS, Fernandez MM. Health outcomes and economics research for regenerative medicine and cellular therapies: lessons from a multi-market health technology assessment and reimbursement review. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A337-8.

Sennfalt K, Ling CS, Pericleous L, Sbarigia U, Gatta F, Kolasa K, Chamberlain G, Pandit P, Zagorska G. The economic burden of post-transplant events in renal transplant patients in UK, Italy, Netherlands, Poland and Belgium. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research; 2011. [abstract] Value Health. 2011 Nov; 14(7):A262-3.

Wolowacz S, Roskell N, Plumb J, Clemens A, Robinson P, Dolan G, Brenkel I. Cost-effectiveness of dabigatran etexilate 150 mg for the prevention of venous thromboembolism in patients undergoing total hip or knee arthroplasty that have moderate impairment of renal function. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 1, 2009. [abstract] Value Health. 2009 May; 12(3):A151.

Mohamed AF, Hauber AB, Medjedovic J, Beam C. Patient preferences and stated adherence for hepatitis c virus treatments. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 19, 2009. [abstract] Value Health. 2009 May; 12(3):A117.

Wolowacz SE, Roskell NS, Plumb JM, Clemens A, Robinson P, Dolan G, Brenkel IJ. Cost-effectiveness of dabigatran etexilate 150 MG for the prevention of venous thromboembolism in patients aged over 75 years undergoing total hip or knee arthroplasty. Poster presented at the 2009 ISPOR 14th Annual International Meeting; May 14, 2009. Orlando, FL. [abstract] Value Health. 2009 May; 12(3):A151.

Irish WD, Wang J. Evaluating cost associated with event-censored data: application to all-cause graft failure following kidney transplantation. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A17.

Irish WD, Sherrill EH. An econometric approach to generating population cost estimates for event-time data: an example using renal transplant failure data. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; 2003. [abstract] Value Health. 2003 May; 6(3):178-9.

Irish W, Sherrill B. An econometric approach to generating population cost estimates for event-time data: an example using renal transplant graft failure data. Value Health. 2003 Jan 1;6(3):178-9.

Legendre C, Lebranchu Y, Durand-Zaleski I, Pouteil-Noble C, Beard S, Crochard A, Ratcliffe J. A survey on the clinical management of CMV risk in patients following renal transplantation in France. Value Health. 2002 Jan 1;5(6):586.